PD-1 Inhibitor Therapy(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)

N/A

Report date: 2023/09/05 20:09:53

Base Information

Drug NamePD-1 Inhibitor Therapy(Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University)
Drug Alias NameAnti-PD-1 inhibitorThe PD-1 monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and NeckCarcinoma, HepatocellularRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital, Sun Yat-Sen UniversitySun Yat-Sen Memorial Hospital Of Sun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and NeckCarcinoma, HepatocellularRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A